Call Number (LC) Title Results
RC271.C5 A38 2013eb Advances in cancer drug targets. 1
RC271.C5 A5 1953 Antimetabolites and cancer : a symposium presented on December 28-29, 1953, at the Boston meeting of the American Association for the Advancement of Science / 1
RC271.C5 A66 1984 Anticancer and interferon agents : synthesis and properties / 1
RC271.C5 A67 Anticancer agents based on natural product models / 2
RC271.C5 A67245 1999eb Anticancer drug toxicity : prevention, management, and clinical pharmacokinetics / 1
RC271.C5 A6725 1994 Anticancer drugs : antimetabolite metabolism and natural anticancer agents / 1
RC271.C5 A6726 1994 Anticancer drugs : reactive metabolism and drug interactions / 1
RC271.C5 A6728 2008eb Anticancer therapeutics 1
RC271.C5 A94 2008eb Medicinal chemistry of anticancer drugs 1
RC271.C5 B49 2008eb Beyond apoptosis : cellular outcomes of cancer therapy / 1
RC271.C5 B78 1993 Coping with chemotherapy / 1
RC271.C5 C28 2022eb Chemotherapy protocols and infusion sequence : schedule considerations in cancer treatment / 1
RC271.C5 C3 Cancer chemotherapy abstracts. 1
RC271.C5 C32219 2011 Cancer chemotherapy and biotherapy : principles and practice / 1
RC271.C5 C322193 Cancer chemotherapy reports. 1
RC271.C5 C3225 2006 Cancer drug resistance / 1
RC271.C5 C358 2022 Cancer drug resistance : methods and protocols / 1
RC271.C5 C36 2016 Cancer drug resistance : overviews and methods / 1
RC271.C5 C36 2019 Cancer stem cell resistance to targeted therapy / 1
RC271.C5 C365 1986 Cell cycle effects of drugs / 1